Thromb Haemost 2000; 83(04): 633-634
DOI: 10.1055/s-0037-1613878
Schattauer GmbH
Continuous Infusion of Recombinant Factor VIIa (NovoSeven®) in the Treatment of a Patient with Type III von Willebrand’s Disease and Alloantibodies against von Willebrand Factor
R.E. Grossmann
1
From the Central Laboratory of the University Medical Centre, University of Wuerzburg, Wuerzburg, Germany
,
U. Geisen
1
From the Central Laboratory of the University Medical Centre, University of Wuerzburg, Wuerzburg, Germany
,
S. Schwender
1
From the Central Laboratory of the University Medical Centre, University of Wuerzburg, Wuerzburg, Germany
,
F. Keller
1
From the Central Laboratory of the University Medical Centre, University of Wuerzburg, Wuerzburg, Germany
› Institutsangaben
